Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Mediastinitis and mycotic aneurysm of the aorta after orthotopic heart transplantation.

Texas Heart Institute journal

Anthuber M, Kemkes BM, Kreuzer E, Gokel M, Schuetz A, Kugler C, Sudhoff F.
PMID: 15227478
Tex Heart Inst J. 1991;18(3):186-93.

After cardiac transplantation, bacterial mediastinitis is a rare but dangerous early complication. Of the 113 patients who underwent heart or heart-lung transplantation at our hospital from August 1981 to April 1989, 8 developed purulent mediastinitis. Treatment involved surgical débridment,...

Cite
Anthuber M, Kemkes BM, Kreuzer E, et al. Mediastinitis and mycotic aneurysm of the aorta after orthotopic heart transplantation. Tex Heart Inst J. 1991;18(3):186-93
Anthuber, M., Kemkes, B. M., Kreuzer, E., Gokel, M., Schuetz, A., Kugler, C., & Sudhoff, F. (1991). Mediastinitis and mycotic aneurysm of the aorta after orthotopic heart transplantation. Texas Heart Institute journal, 18(3), 186-93.
Anthuber, M, et al. "Mediastinitis and mycotic aneurysm of the aorta after orthotopic heart transplantation." Texas Heart Institute journal vol. 18,3 (1991): 186-93.
Anthuber M, Kemkes BM, Kreuzer E, Gokel M, Schuetz A, Kugler C, Sudhoff F. Mediastinitis and mycotic aneurysm of the aorta after orthotopic heart transplantation. Tex Heart Inst J. 1991;18(3):186-93. PMID: 15227478; PMCID: PMC324995.
Copy Download .nbib Format: NLM
Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy.

International journal of clinical and experimental medicine

Weiss DR, Juchem G, Kemkes BM, Gansera B, Nees S.
PMID: 19684884
Int J Clin Exp Med. 2009 May 28;2(2):95-113.

The objective of this study was to gain deeper insight into the early reasons for saphenous vein graft disease and to find a practical approach to obviate it. Intraoperative storage of freshly explanted venous grafts (45 min, 20 degrees...

Cite
Weiss DR, Juchem G, Kemkes BM, et al. Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy. Int J Clin Exp Med. 2009;2(2):95-113
Weiss, D. R., Juchem, G., Kemkes, B. M., Gansera, B., & Nees, S. (2009). Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy. International journal of clinical and experimental medicine, 2(2), 95-113.
Weiss, Dominik R, et al. "Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy." International journal of clinical and experimental medicine vol. 2,2 (2009): 95-113.
Weiss DR, Juchem G, Kemkes BM, Gansera B, Nees S. Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy. Int J Clin Exp Med. 2009 May 28;2(2):95-113. PMID: 19684884; PMCID: PMC2719701.
Copy Download .nbib Format: NLM
Unzipping empathy in psychopathy: Empathy and facial affect processing in psychopaths.

Neuroscience and biobehavioral reviews

Rijnders RJP, Terburg D, Bos PA, Kempes MM, van Honk J.
PMID: 34695456
Neurosci Biobehav Rev. 2021 Dec;131:1116-1126. doi: 10.1016/j.neubiorev.2021.10.020. Epub 2021 Oct 22.

Psychopathy is a neurodevelopmental disorder that has a highly deleterious effect upon both individuals and society at large. Psychopaths grossly neglect and disrespect the interests of others. Their antisocial behavior is thought to originate from a lack of empathy....

Cite
Rijnders RJP, Terburg D, Bos PA, et al. Unzipping empathy in psychopathy: Empathy and facial affect processing in psychopaths. Neurosci Biobehav Rev. 2021;131:1116-1126doi: 10.1016/j.neubiorev.2021.10.020.
Rijnders, R. J. P., Terburg, D., Bos, P. A., Kempes, M. M., & van Honk, J. (2021). Unzipping empathy in psychopathy: Empathy and facial affect processing in psychopaths. Neuroscience and biobehavioral reviews, 1311116-1126. https://doi.org/10.1016/j.neubiorev.2021.10.020
Rijnders, Ronald J P, et al. "Unzipping empathy in psychopathy: Empathy and facial affect processing in psychopaths." Neuroscience and biobehavioral reviews vol. 131 (2021): 1116-1126. doi: https://doi.org/10.1016/j.neubiorev.2021.10.020
Rijnders RJP, Terburg D, Bos PA, Kempes MM, van Honk J. Unzipping empathy in psychopathy: Empathy and facial affect processing in psychopaths. Neurosci Biobehav Rev. 2021 Dec;131:1116-1126. doi: 10.1016/j.neubiorev.2021.10.020. Epub 2021 Oct 22. PMID: 34695456.
Copy Download .nbib Format: NLM
Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.

Molecular oncology

Pierobon M, Robert NJ, Northfelt DW, Jahanzeb M, Wong S, Hodge KA, Baldelli E, Aldrich J, Craig DW, Liotta LA, Avramovic S, Wojtusiak J, Alemi F, Wulfkuhle JD, Bellos A, Gallagher RI, Arguello D, Conrad A, Kemkes A, Loesch DM, Vocila L, Dunetz B, Carpten JD, Petricoin EF, Anthony SP.
PMID: 34437759
Mol Oncol. 2021 Aug 26; doi: 10.1002/1878-0261.13091. Epub 2021 Aug 26.

This prospective phase II clinical trial (Side Out 2) explored the clinical benefits of treatment selection informed by multi-omic molecular profiling (MoMP) in refractory metastatic breast cancers (MBCs). Core needle biopsies were collected from 32 patients with MBC at...

Cite
Pierobon M, Robert NJ, Northfelt DW, et al. Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial. Mol Oncol. 2021;doi: 10.1002/1878-0261.13091.
Pierobon, M., Robert, N. J., Northfelt, D. W., Jahanzeb, M., Wong, S., Hodge, K. A., Baldelli, E., Aldrich, J., Craig, D. W., Liotta, L. A., Avramovic, S., Wojtusiak, J., Alemi, F., Wulfkuhle, J. D., Bellos, A., Gallagher, R. I., Arguello, D., Conrad, A., Kemkes, A., Loesch, D. M., Vocila, L., Dunetz, B., Carpten, J. D., Petricoin, E. F., & Anthony, S. P. (2021). Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial. Molecular oncology, . https://doi.org/10.1002/1878-0261.13091
Pierobon, Mariaelena, et al. "Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial." Molecular oncology vol. (2021). doi: https://doi.org/10.1002/1878-0261.13091
Pierobon M, Robert NJ, Northfelt DW, Jahanzeb M, Wong S, Hodge KA, Baldelli E, Aldrich J, Craig DW, Liotta LA, Avramovic S, Wojtusiak J, Alemi F, Wulfkuhle JD, Bellos A, Gallagher RI, Arguello D, Conrad A, Kemkes A, Loesch DM, Vocila L, Dunetz B, Carpten JD, Petricoin EF, Anthony SP. Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial. Mol Oncol. 2021 Aug 26; doi: 10.1002/1878-0261.13091. Epub 2021 Aug 26. PMID: 34437759.
Copy Download .nbib Format: NLM
Restraint Stress Intensifies Interstitial K(+) Accumulation during Severe Hypoxia.

Frontiers in pharmacology

Schnell C, Janc OA, Kempkes B, Callis CA, Flügge G, Hülsmann S, Müller M.
PMID: 22470344
Front Pharmacol. 2012 Mar 28;3:53. doi: 10.3389/fphar.2012.00053. eCollection 2012.

Chronic stress affects neuronal networks by inducing dendritic retraction, modifying neuronal excitability and plasticity, and modulating glial cells. To elucidate the functional consequences of chronic stress for the hippocampal network, we submitted adult rats to daily restraint stress for...

Cite
Schnell C, Janc OA, Kempkes B, et al. Restraint Stress Intensifies Interstitial K(+) Accumulation during Severe Hypoxia. Front Pharmacol. 2012;3:53doi: 10.3389/fphar.2012.00053.
Schnell, C., Janc, O. A., Kempkes, B., Callis, C. A., Flügge, G., Hülsmann, S., & Müller, M. (2012). Restraint Stress Intensifies Interstitial K(+) Accumulation during Severe Hypoxia. Frontiers in pharmacology, 353. https://doi.org/10.3389/fphar.2012.00053
Schnell, Christian, et al. "Restraint Stress Intensifies Interstitial K(+) Accumulation during Severe Hypoxia." Frontiers in pharmacology vol. 3 (2012): 53. doi: https://doi.org/10.3389/fphar.2012.00053
Schnell C, Janc OA, Kempkes B, Callis CA, Flügge G, Hülsmann S, Müller M. Restraint Stress Intensifies Interstitial K(+) Accumulation during Severe Hypoxia. Front Pharmacol. 2012 Mar 28;3:53. doi: 10.3389/fphar.2012.00053. eCollection 2012. PMID: 22470344; PMCID: PMC3314232.
Copy Download .nbib Format: NLM
[Surgical indications in goiter].

Die Medizinische Welt

KEMKES HB.
PMID: 14842630
Med Welt. 1951 Apr 28;20(17):568-71.

No abstract available.

Cite
KEMKES HB. Gedanken zur Indikationsstellung bei Kropfoperationen. [Surgical indications in goiter]. Med Welt. 1951;20(17):568-71
KEMKES, H. B. (1951). Gedanken zur Indikationsstellung bei Kropfoperationen. [Surgical indications in goiter]. Die Medizinische Welt, 20(17), 568-71.
KEMKES, H B. "Gedanken zur Indikationsstellung bei Kropfoperationen." [Surgical indications in goiter]. Die Medizinische Welt vol. 20,17 (1951): 568-71.
KEMKES HB. Gedanken zur Indikationsstellung bei Kropfoperationen. [Surgical indications in goiter]. Med Welt. 1951 Apr 28;20(17):568-71. Undetermined. PMID: 14842630.
Copy Download .nbib Format: NLM
New methods for noninvasive monitoring of rejection after heart transplantation.

Texas Heart Institute journal

Reichenspumer H, Haberl R, Angermann C, Anthuber M, Osterholzer G, Kemkes BM, Hammer C, Gokel JM, Reichart B.
PMID: 15227271
Tex Heart Inst J. 1988;15(1):7-11.

Between August 1981 and February 1987, 67 orthotopic heart transplants and three heart-lung transplants were performed in 69 patients at the University of Munich Hospital. The immunosuppressive regimen consisted of cyclosporine A, azathioprine, and prednisone. The diagnosis of acute...

Cite
Reichenspumer H, Haberl R, Angermann C, et al. New methods for noninvasive monitoring of rejection after heart transplantation. Tex Heart Inst J. 1988;15(1):7-11
Reichenspumer, H., Haberl, R., Angermann, C., Anthuber, M., Osterholzer, G., Kemkes, B. M., Hammer, C., Gokel, J. M., & Reichart, B. (1988). New methods for noninvasive monitoring of rejection after heart transplantation. Texas Heart Institute journal, 15(1), 7-11.
Reichenspumer, H, et al. "New methods for noninvasive monitoring of rejection after heart transplantation." Texas Heart Institute journal vol. 15,1 (1988): 7-11.
Reichenspumer H, Haberl R, Angermann C, Anthuber M, Osterholzer G, Kemkes BM, Hammer C, Gokel JM, Reichart B. New methods for noninvasive monitoring of rejection after heart transplantation. Tex Heart Inst J. 1988;15(1):7-11. PMID: 15227271; PMCID: PMC324776.
Copy Download .nbib Format: NLM
Search for optimized conditions for sealing and storage of bypass vessels: influence of preservation solution and filling pressure on the degree of endothelialization.

International journal of clinical and experimental medicine

Weiss DR, Juchem G, Eblenkamp M, Kemkes BM, Gansera B, Geier M, Nees S.
PMID: 20369036
Int J Clin Exp Med. 2010 Jan 01;3(1):10-27.

The aim of the present study was to develop methods for the rapid assessment of intimal quality of coronary bypass segments of venous origin, and to prevent endothelial damage by improved intraoperative handling of graft segments. Particular attention was...

Cite
Weiss DR, Juchem G, Eblenkamp M, et al. Search for optimized conditions for sealing and storage of bypass vessels: influence of preservation solution and filling pressure on the degree of endothelialization. Int J Clin Exp Med. 2010;3(1):10-27
Weiss, D. R., Juchem, G., Eblenkamp, M., Kemkes, B. M., Gansera, B., Geier, M., & Nees, S. (2010). Search for optimized conditions for sealing and storage of bypass vessels: influence of preservation solution and filling pressure on the degree of endothelialization. International journal of clinical and experimental medicine, 3(1), 10-27.
Weiss, Dominik Roger, et al. "Search for optimized conditions for sealing and storage of bypass vessels: influence of preservation solution and filling pressure on the degree of endothelialization." International journal of clinical and experimental medicine vol. 3,1 (2010): 10-27.
Weiss DR, Juchem G, Eblenkamp M, Kemkes BM, Gansera B, Geier M, Nees S. Search for optimized conditions for sealing and storage of bypass vessels: influence of preservation solution and filling pressure on the degree of endothelialization. Int J Clin Exp Med. 2010 Jan 01;3(1):10-27. PMID: 20369036; PMCID: PMC2848302.
Copy Download .nbib Format: NLM
PLK1-dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV-infected mice.

EMBO reports

Zhang X, Schuhmachers P, Mourão A, Giansanti P, Murer A, Thumann S, Kuklik-Roos C, Beer S, Hauck SM, Hammerschmidt W, Küppers R, Kuster B, Raab M, Strebhardt K, Sattler M, Münz C, Kempkes B.
PMID: 34605140
EMBO Rep. 2021 Dec 06;22(12):e53007. doi: 10.15252/embr.202153007. Epub 2021 Oct 04.

While Epstein-Barr virus (EBV) establishes a life-long latent infection in apparently healthy human immunocompetent hosts, immunodeficient individuals are at particular risk to develop lymphoproliferative B-cell malignancies caused by EBV. A key EBV protein is the transcription factor EBV nuclear...

Cite
Zhang X, Schuhmachers P, Mourão A, et al. PLK1-dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV-infected mice. EMBO Rep. 2021;22(12):e53007doi: 10.15252/embr.202153007.
Zhang, X., Schuhmachers, P., Mourão, A., Giansanti, P., Murer, A., Thumann, S., Kuklik-Roos, C., Beer, S., Hauck, S. M., Hammerschmidt, W., Küppers, R., Kuster, B., Raab, M., Strebhardt, K., Sattler, M., Münz, C., & Kempkes, B. (2021). PLK1-dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV-infected mice. EMBO reports, 22(12), e53007. https://doi.org/10.15252/embr.202153007
Zhang, Xiang, et al. "PLK1-dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV-infected mice." EMBO reports vol. 22,12 (2021): e53007. doi: https://doi.org/10.15252/embr.202153007
Zhang X, Schuhmachers P, Mourão A, Giansanti P, Murer A, Thumann S, Kuklik-Roos C, Beer S, Hauck SM, Hammerschmidt W, Küppers R, Kuster B, Raab M, Strebhardt K, Sattler M, Münz C, Kempkes B. PLK1-dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV-infected mice. EMBO Rep. 2021 Dec 06;22(12):e53007. doi: 10.15252/embr.202153007. Epub 2021 Oct 04. PMID: 34605140.
Copy Download .nbib Format: NLM
Systemic Radical Scavenger Treatment of a Mouse Model of Rett Syndrome: Merits and Limitations of the Vitamin E Derivative Trolox.

Frontiers in cellular neuroscience

Janc OA, Hüser MA, Dietrich K, Kempkes B, Menzfeld C, Hülsmann S, Müller M.
PMID: 27895554
Front Cell Neurosci. 2016 Nov 15;10:266. doi: 10.3389/fncel.2016.00266. eCollection 2016.

Rett syndrome (RTT) is a severe neurodevelopmental disorder typically arising from spontaneous mutations in the X-chromosomal methyl-CpG binding protein 2 (

Cite
Janc OA, Hüser MA, Dietrich K, et al. Systemic Radical Scavenger Treatment of a Mouse Model of Rett Syndrome: Merits and Limitations of the Vitamin E Derivative Trolox. Front Cell Neurosci. 2016;10:266doi: 10.3389/fncel.2016.00266.
Janc, O. A., Hüser, M. A., Dietrich, K., Kempkes, B., Menzfeld, C., Hülsmann, S., & Müller, M. (2016). Systemic Radical Scavenger Treatment of a Mouse Model of Rett Syndrome: Merits and Limitations of the Vitamin E Derivative Trolox. Frontiers in cellular neuroscience, 10266. https://doi.org/10.3389/fncel.2016.00266
Janc, Oliwia A, et al. "Systemic Radical Scavenger Treatment of a Mouse Model of Rett Syndrome: Merits and Limitations of the Vitamin E Derivative Trolox." Frontiers in cellular neuroscience vol. 10 (2016): 266. doi: https://doi.org/10.3389/fncel.2016.00266
Janc OA, Hüser MA, Dietrich K, Kempkes B, Menzfeld C, Hülsmann S, Müller M. Systemic Radical Scavenger Treatment of a Mouse Model of Rett Syndrome: Merits and Limitations of the Vitamin E Derivative Trolox. Front Cell Neurosci. 2016 Nov 15;10:266. doi: 10.3389/fncel.2016.00266. eCollection 2016. PMID: 27895554; PMCID: PMC5109403.
Copy Download .nbib Format: NLM
Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.

Molecular oncology

Pierobon M, Robert NJ, Northfelt DW, Jahanzeb M, Wong S, Hodge KA, Baldelli E, Aldrich J, Craig DW, Liotta LA, Avramovic S, Wojtusiak J, Alemi F, Wulfkuhle JD, Bellos A, Gallagher RI, Arguello D, Conrad A, Kemkes A, Loesch DM, Vocila L, Dunetz B, Carpten JD, Petricoin EF, Anthony SP.
PMID: 34437759
Mol Oncol. 2022 Jan;16(1):104-115. doi: 10.1002/1878-0261.13091. Epub 2021 Sep 12.

This prospective phase II clinical trial (Side Out 2) explored the clinical benefits of treatment selection informed by multi-omic molecular profiling (MoMP) in refractory metastatic breast cancers (MBCs). Core needle biopsies were collected from 32 patients with MBC at...

Cite
Pierobon M, Robert NJ, Northfelt DW, et al. Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial. Mol Oncol. 2021;16(1):104-115doi: 10.1002/1878-0261.13091.
Pierobon, M., Robert, N. J., Northfelt, D. W., Jahanzeb, M., Wong, S., Hodge, K. A., Baldelli, E., Aldrich, J., Craig, D. W., Liotta, L. A., Avramovic, S., Wojtusiak, J., Alemi, F., Wulfkuhle, J. D., Bellos, A., Gallagher, R. I., Arguello, D., Conrad, A., Kemkes, A., Loesch, D. M., Vocila, L., Dunetz, B., Carpten, J. D., Petricoin, E. F., & Anthony, S. P. (2022). Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial. Molecular oncology, 16(1), 104-115. https://doi.org/10.1002/1878-0261.13091
Pierobon, Mariaelena, et al. "Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial." Molecular oncology vol. 16,1 (2022): 104-115. doi: https://doi.org/10.1002/1878-0261.13091
Pierobon M, Robert NJ, Northfelt DW, Jahanzeb M, Wong S, Hodge KA, Baldelli E, Aldrich J, Craig DW, Liotta LA, Avramovic S, Wojtusiak J, Alemi F, Wulfkuhle JD, Bellos A, Gallagher RI, Arguello D, Conrad A, Kemkes A, Loesch DM, Vocila L, Dunetz B, Carpten JD, Petricoin EF, Anthony SP. Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial. Mol Oncol. 2022 Jan;16(1):104-115. doi: 10.1002/1878-0261.13091. Epub 2021 Sep 12. PMID: 34437759.
Copy Download .nbib Format: NLM
Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.

Molecular oncology

Pierobon M, Robert NJ, Northfelt DW, Jahanzeb M, Wong S, Hodge KA, Baldelli E, Aldrich J, Craig DW, Liotta LA, Avramovic S, Wojtusiak J, Alemi F, Wulfkuhle JD, Bellos A, Gallagher RI, Arguello D, Conrad A, Kemkes A, Loesch DM, Vocila L, Dunetz B, Carpten JD, Petricoin EF, Anthony SP.
PMID: 34437759
Mol Oncol. 2022 Jan;16(1):104-115. doi: 10.1002/1878-0261.13091. Epub 2021 Sep 12.

This prospective phase II clinical trial (Side Out 2) explored the clinical benefits of treatment selection informed by multi-omic molecular profiling (MoMP) in refractory metastatic breast cancers (MBCs). Core needle biopsies were collected from 32 patients with MBC at...

Cite
Pierobon M, Robert NJ, Northfelt DW, et al. Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial. Mol Oncol. 2021;16(1):104-115doi: 10.1002/1878-0261.13091.
Pierobon, M., Robert, N. J., Northfelt, D. W., Jahanzeb, M., Wong, S., Hodge, K. A., Baldelli, E., Aldrich, J., Craig, D. W., Liotta, L. A., Avramovic, S., Wojtusiak, J., Alemi, F., Wulfkuhle, J. D., Bellos, A., Gallagher, R. I., Arguello, D., Conrad, A., Kemkes, A., Loesch, D. M., Vocila, L., Dunetz, B., Carpten, J. D., Petricoin, E. F., & Anthony, S. P. (2022). Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial. Molecular oncology, 16(1), 104-115. https://doi.org/10.1002/1878-0261.13091
Pierobon, Mariaelena, et al. "Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial." Molecular oncology vol. 16,1 (2022): 104-115. doi: https://doi.org/10.1002/1878-0261.13091
Pierobon M, Robert NJ, Northfelt DW, Jahanzeb M, Wong S, Hodge KA, Baldelli E, Aldrich J, Craig DW, Liotta LA, Avramovic S, Wojtusiak J, Alemi F, Wulfkuhle JD, Bellos A, Gallagher RI, Arguello D, Conrad A, Kemkes A, Loesch DM, Vocila L, Dunetz B, Carpten JD, Petricoin EF, Anthony SP. Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial. Mol Oncol. 2022 Jan;16(1):104-115. doi: 10.1002/1878-0261.13091. Epub 2021 Sep 12. PMID: 34437759; PMCID: PMC8732340.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries